NNVC

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

NanoViricides Inc

NYSE MKT | NNVC

1.12

USD

$0.00

(

0.00%

)

At Close (As of Dec 1, 2025)

$21.96M

Market Cap

-

P/E Ratio

-0.5

EPS

$2.23

52 Week High

$0.94

52 Week Low

HEALTHCARE

Sector

NNVC Chart

Recent Chart
Price Action

NNVC Technicals

Tags:

NNVC Earnings

Yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -$744K
Total Revenue $0
Cost Of Revenue $744K
Costof Goods And Services Sold $744K
Operating Income -$9.6M
Selling General And Administrative $4M
Research And Development $5.5M
Operating Expenses $9.6M
Investment Income Net -
Net Interest Income $125K
Interest Income $125K
Interest Expense $149M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $744K
Income Before Tax -$9.5M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.5M
Comprehensive Income Net Of Tax -
Ebit -$9.5M
Ebitda -$8.7M
Net Income -$9.5M

Revenue & Profitability

Earnings Performance

NNVC Financials

yearly Balance Sheet (As of Jun 30, 2025)

Field Value (USD)
Total Assets $8.8M
Total Current Assets $1.7M
Cash And Cash Equivalents At Carrying Value $1.6M
Cash And Short Term Investments $1.6M
Inventory -
Current Net Receivables -
Total Non Current Assets $7.2M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $317K
Intangible Assets Excluding Goodwill $317K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $112K
Other Non Current Assets -
Total Liabilities $1.3M
Total Current Liabilities $1.3M
Current Accounts Payable $1.3M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $26K
Other Non Current Liabilities -
Total Shareholder Equity $7.5M
Treasury Stock -
Retained Earnings -$149M
Common Stock $166
Common Stock Shares Outstanding $15M

yearly Cash Flow (As of Jun 30, 2025)

Field Value (USD)
Operating Cashflow -$8.5M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $744K
Capital Expenditures $57K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$57K
Cashflow From Financing $5.3M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$9.5M

yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -$744K
Total Revenue $0
Cost Of Revenue $744K
Costof Goods And Services Sold $744K
Operating Income -$9.6M
Selling General And Administrative $4M
Research And Development $5.5M
Operating Expenses $9.6M
Investment Income Net -
Net Interest Income $125K
Interest Income $125K
Interest Expense $149M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $744K
Income Before Tax -$9.5M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.5M
Comprehensive Income Net Of Tax -
Ebit -$9.5M
Ebitda -$8.7M
Net Income -$9.5M

NNVC News

NNVC Profile

NanoViricides Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

NanoViricides Inc. (NNVC) is an innovative nanobiopharmaceutical firm headquartered in Shelton, Connecticut, dedicated to the research and development of cutting-edge antiviral therapies. Leveraging its proprietary nanomedicine platform, the company creates targeted treatments that address various viral infections and significant unmet medical needs within the healthcare sector. With a robust clinical and preclinical pipeline, NanoViricides is well-positioned for substantial growth in the evolving landscape of antiviral solutions and continues to make strides in bringing its advanced therapies to market.

LPTX
+368.57%
$2.05
DRCT
+7.89%
$0.12
PAVS
-93.54%
$0.06
QTTB
+95.43%
$4.28
KALA
+67.68%
$1.62
NVDA
+1.50%
$179.65
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
FTEL
+36.47%
$1.16
AXDX
-61.36%
$0.03
BITF
-6.46%
$3.25
IVP
+1.36%
$0.12
ASST
-7.14%
$1.04
ADAP
-15.14%
$0.05
PLUG
-1.99%
$1.97
CHR
+4.33%
$0.04
AAL
-0.26%
$14.01
BURU
-4.70%
$0.23
INTC
-1.54%
$39.93
SOND
-23.45%
$0.12
TLRY
-2.42%
$0.79
RMBL
+60.50%
$3.21
BMNR
-12.19%
$29.08
LNW
-3.71%
$86.22
NIO
-5.55%
$5.19
NFE
+13.11%
$1.38
ADD
-25.47%
$0.05
TSLA
-0.02%
$430.06
AHMA
+154.65%
$12.24
BMNU
-24.73%
$6.16
SRM
+53.27%
$10.30
CNEY
-12.02%
$1.28
IRBT
+14.50%
$1.80
RPGL
+2.86%
$0.41
BYND
+2.87%
$1.01
INHD
-23.53%
$0.17
ONDS
-2.91%
$7.67
CLSK
-3.52%
$14.56
SOFI
-0.65%
$29.52
YGMZ
-0.26%
$0.11
MARA
-3.76%
$11.36
WLGS
-5.57%
$0.04
SNAP
-0.20%
$7.66
F
0.00%
$13.28
MTSR
-0.35%
$70.50
PFE
-1.61%
$25.32
CIFR
-1.40%
$20.06
RIVN
+4.81%
$17.67
BTG
-0.75%
$4.58
MSTR
-9.97%
$159.50
CAN
-6.40%
$0.94
GRAB
+2.44%
$5.45
AFMD
-34.94%
$0.18
SMX
+250.80%
$61.04
BTBT
-6.72%
$2.22
HOOD
-4.60%
$122.57
IBRX
+10.79%
$2.36
ACHR
-2.25%
$7.61
RIG
+0.45%
$4.43
NWTN
-9.09%
$0.70
AMZN
+0.75%
$234.97
GRYP
-10.38%
$1.38
AMD
+0.99%
$219.68
MODV
-25.22%
$0.43
NCT
-30.40%
$0.54
DNN
0.00%
$2.56
WULF
-0.85%
$15.37
PLTR
+0.13%
$168.68
GOOGL
-0.76%
$317.71
SMR
+5.04%
$20.00
AG
+3.02%
$15.69
EXK
-4.28%
$9.50
RUBI
-12.53%
$0.13
T
+0.77%
$26.02
HBAN
+1.50%
$16.54
PLTD
+0.05%
$7.04
AMC
+6.52%
$2.45
BBD
-1.35%
$3.65
VHAI
-25.00%
$0.00
ITUB
-1.27%
$7.70
DVLT
-4.18%
$1.94
APLD
+4.53%
$28.32
RGTI
-6.11%
$24.00
CPNG
-4.33%
$26.93
SAND
-6.04%
$12.12
BTE
+1.89%
$3.22
GPUS
-8.47%
$0.27
IREN
+0.37%
$47.99
HL
+2.72%
$17.27
SHOT
-74.37%
$0.39
TE
+13.26%
$4.66
WBUY
+35.51%
$2.14
ZAPP
-46.30%
$0.15
AAPL
+0.28%
$279.64
VALE
+0.71%
$12.70
CRWV
+3.56%
$75.72
CMG
+1.43%
$34.52
GOOG
-0.77%
$317.63
LPTX
+368.57%
$2.05
DRCT
+7.89%
$0.12
PAVS
-93.54%
$0.06
QTTB
+95.43%
$4.28
KALA
+67.68%
$1.62
NVDA
+1.50%
$179.65
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
FTEL
+36.47%
$1.16
AXDX
-61.36%
$0.03
BITF
-6.46%
$3.25
IVP
+1.36%
$0.12
ASST
-7.14%
$1.04
ADAP
-15.14%
$0.05
PLUG
-1.99%
$1.97
CHR
+4.33%
$0.04
AAL
-0.26%
$14.01
BURU
-4.70%
$0.23
INTC
-1.54%
$39.93
SOND
-23.45%
$0.12
TLRY
-2.42%
$0.79
RMBL
+60.50%
$3.21
BMNR
-12.19%
$29.08
LNW
-3.71%
$86.22
NIO
-5.55%
$5.19
NFE
+13.11%
$1.38
ADD
-25.47%
$0.05
TSLA
-0.02%
$430.06
AHMA
+154.65%
$12.24
BMNU
-24.73%
$6.16
SRM
+53.27%
$10.30
CNEY
-12.02%
$1.28
IRBT
+14.50%
$1.80
RPGL
+2.86%
$0.41
BYND
+2.87%
$1.01
INHD
-23.53%
$0.17
ONDS
-2.91%
$7.67
CLSK
-3.52%
$14.56
SOFI
-0.65%
$29.52
YGMZ
-0.26%
$0.11
MARA
-3.76%
$11.36
WLGS
-5.57%
$0.04
SNAP
-0.20%
$7.66
F
0.00%
$13.28
MTSR
-0.35%
$70.50
PFE
-1.61%
$25.32
CIFR
-1.40%
$20.06
RIVN
+4.81%
$17.67
BTG
-0.75%
$4.58
MSTR
-9.97%
$159.50
CAN
-6.40%
$0.94
GRAB
+2.44%
$5.45
AFMD
-34.94%
$0.18
SMX
+250.80%
$61.04
BTBT
-6.72%
$2.22
HOOD
-4.60%
$122.57
IBRX
+10.79%
$2.36
ACHR
-2.25%
$7.61
RIG
+0.45%
$4.43
NWTN
-9.09%
$0.70
AMZN
+0.75%
$234.97
GRYP
-10.38%
$1.38
AMD
+0.99%
$219.68
MODV
-25.22%
$0.43
NCT
-30.40%
$0.54
DNN
0.00%
$2.56
WULF
-0.85%
$15.37
PLTR
+0.13%
$168.68
GOOGL
-0.76%
$317.71
SMR
+5.04%
$20.00
AG
+3.02%
$15.69
EXK
-4.28%
$9.50
RUBI
-12.53%
$0.13
T
+0.77%
$26.02
HBAN
+1.50%
$16.54
PLTD
+0.05%
$7.04
AMC
+6.52%
$2.45
BBD
-1.35%
$3.65
VHAI
-25.00%
$0.00
ITUB
-1.27%
$7.70
DVLT
-4.18%
$1.94
APLD
+4.53%
$28.32
RGTI
-6.11%
$24.00
CPNG
-4.33%
$26.93
SAND
-6.04%
$12.12
BTE
+1.89%
$3.22
GPUS
-8.47%
$0.27
IREN
+0.37%
$47.99
HL
+2.72%
$17.27
SHOT
-74.37%
$0.39
TE
+13.26%
$4.66
WBUY
+35.51%
$2.14
ZAPP
-46.30%
$0.15
AAPL
+0.28%
$279.64
VALE
+0.71%
$12.70
CRWV
+3.56%
$75.72
CMG
+1.43%
$34.52
GOOG
-0.77%
$317.63
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.